Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyruan-One vs Hylan G-F 20 in Knee Osteoarthritis
NCT03484091Phase 4Completed
- Sponsor
- Thammasat University
- Start
- Apr 2018
- Primary completion
- Jun 2023
- Modality
- Polymer-based Nanoparticles, Hydrogel Systems
- Countries
- 1
01
Overview
A Phase 4 trial of BDDE-crosslinked sodium hyaluronate in knee osteoarthritis (OA), sponsored by Thammasat University. Started Apr 2018; status: completed.
02
Drugs
BDDE-crosslinked sodium hyaluronate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03484091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03484091.